Okava has been investigating the use of GLP-1 receptors in cats and found it has similar effects to weight-loss drugs on humans.
The San Francisco-based company is hoping to develop a long-acting implant as opposed to regular injections.
But, Healthy Pets New Zealand trustee and vet Dr Cath Watson says weight loss drugs should not be the first option for pets.
Watson told Andrew Dickens that pet obesity levels are "pretty bad and getting worse".
LISTEN ABOVE

Full Show Podcast: 08 May 2026
1:40:29

Winston Peters: NZ First leader says Nats, Labour have record of 'attacking super'
05:25

Perspective with Heather du Plessis-Allan: The media is under scrutiny and we've had it coming
02:22